IRIS
NAVARINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.036
NA - Nord America 1.157
EU - Europa 631
SA - Sud America 266
AF - Africa 42
OC - Oceania 14
Totale 7.146
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.787
US - Stati Uniti d'America 1.083
CN - Cina 607
HK - Hong Kong 369
BR - Brasile 208
GB - Regno Unito 154
IT - Italia 154
VN - Vietnam 130
DE - Germania 82
NL - Olanda 63
CA - Canada 42
IN - India 40
FI - Finlandia 36
MX - Messico 28
JP - Giappone 20
AT - Austria 19
ES - Italia 18
ID - Indonesia 18
TR - Turchia 18
AR - Argentina 17
ZA - Sudafrica 17
EC - Ecuador 16
PL - Polonia 16
UA - Ucraina 16
FR - Francia 15
AU - Australia 12
BD - Bangladesh 12
LT - Lituania 11
EG - Egitto 10
CO - Colombia 9
RU - Federazione Russa 9
PE - Perù 8
DK - Danimarca 6
CZ - Repubblica Ceca 5
SE - Svezia 5
BG - Bulgaria 4
CL - Cile 4
IL - Israele 4
UZ - Uzbekistan 4
EE - Estonia 3
IR - Iran 3
KE - Kenya 3
LB - Libano 3
MA - Marocco 3
RO - Romania 3
TH - Thailandia 3
TL - Timor Orientale 3
TN - Tunisia 3
GT - Guatemala 2
KZ - Kazakistan 2
LV - Lettonia 2
MY - Malesia 2
NC - Nuova Caledonia 2
PH - Filippine 2
PY - Paraguay 2
RS - Serbia 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BJ - Benin 1
BO - Bolivia 1
CH - Svizzera 1
CV - Capo Verde 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
IQ - Iraq 1
IS - Islanda 1
KR - Corea 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
NO - Norvegia 1
PK - Pakistan 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
YT - Mayotte 1
Totale 7.146
Salva come PNG Salva come JPEG
Città #
Singapore 397
Hong Kong 362
Dallas 262
Hefei 257
Ashburn 198
Boardman 135
London 120
Beijing 115
Shanghai 81
Council Bluffs 73
Amsterdam 52
Ho Chi Minh City 52
Munich 50
Rome 41
Los Angeles 37
Hanoi 26
Santa Clara 24
Turku 23
São Paulo 19
Toronto 18
Ankara 16
San Francisco 16
Bari 15
Pune 15
Tokyo 15
Washington 15
Brooklyn 14
Mexico City 14
New York 14
Warsaw 14
Atlanta 12
Helsinki 12
Chennai 11
Haiphong 10
Hangzhou 10
Boston 9
Jinan 9
Johannesburg 9
Seattle 9
Chicago 8
Jaguariúna 8
Nuremberg 8
Qingdao 8
West Jordan 8
Changsha 7
Guangzhou 7
Leicester 7
Montreal 7
Charlotte 6
Guayaquil 6
Las Vegas 6
Melbourne 6
Milan 6
Naples 6
Manaus 5
Paris 5
Pisa 5
Rio de Janeiro 5
Vienna 5
Brasília 4
Brno 4
Chaozhou 4
Cotia 4
Hải Dương 4
Kongens Lyngby 4
Noicattaro 4
Porto Alegre 4
Secaucus 4
Shijiazhuang 4
State College 4
Stockholm 4
Sydney 4
Thái Bình 4
Xi'an 4
Bauru 3
Biên Hòa 3
Buenos Aires 3
Cape Town 3
Chengdu 3
Denver 3
Dili 3
Frankfurt am Main 3
Guarulhos 3
Lima 3
Nairobi 3
New Delhi 3
Poplar 3
Quito 3
Redmond 3
Sofia 3
São Luís 3
Tel Aviv 3
Tunis 3
Alexandria 2
Americana 2
Anantapur 2
Barcelona 2
Barranquilla 2
Belgrade 2
Blumenau 2
Totale 2.841
Salva come PNG Salva come JPEG
Nome #
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 204
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 198
Hepatic PPARs: their role in liver physiology, fibrosis and treatment 197
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 191
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 186
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 179
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 173
Leptin in immuno-rheumatological diseases 172
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 167
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 165
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 153
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 151
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 128
Adult-onset Still's disease with elderly onset: results from a multicentre study 123
Personal attitudes and denialist views about the COVID-19 pandemic in Italy: a national survey 121
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 120
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 107
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 100
A longitudinal study on caring behaviors of Italian nursing students 97
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 97
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 95
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 95
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 90
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 89
Beauty is not perfection: what Leonardo’s Lady with an Ermine can suggest to aesthetic surgery 89
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 88
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 88
Cannabinoids in Autoimmune and Rheumatic Diseases 87
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 85
Leptin in autoimmune mechanisms of systemic rheumatic diseases 85
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 83
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 82
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 69
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 66
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 66
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 65
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 59
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 55
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 55
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 54
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 50
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 49
Polypharmacy is a determinant of hospitalization in Parkinson's disease 48
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 45
The Association of Olfactory Dysfunction, Frailty, and Mortality Is Mediated by Inflammation: Results from the InCHIANTI Study 44
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 43
Development and implementation of the AIDA International Registry for patients with Behçet's disease 40
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 40
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 38
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 38
Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients 36
LOW-DOSE ASPIRIN MAY HAVE A ROLE AS PRIMARY PROPHYLAXIS OF CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS: EVIDENCE FROM AN ITALIAN MULTICENTRIC RETROSPECTIVE STUDY 36
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 36
Co-Occurrence of Anti-Synthetase Syndrome and Sjögren Disease: A Case-Based Review 35
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 35
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 35
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach 35
The Patrick-FABER test in detecting active sacroiliitis in spondyloarthritis patients: a prospective study using magnetic resonance as reference standard 35
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 35
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 35
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres 34
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 34
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 34
Association Between the Use of Oral Contraceptives and the Development of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 34
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 34
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 34
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 33
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 33
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 32
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 32
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 32
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 32
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 32
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 31
Matters of the heart: The case of TNF-alpha targeting drugs 31
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 31
Euthymic despite pain: the role of cognitive reappraisal and experiential avoidance in autoimmune inflammatory rheumatic diseases—a cross-sectional study 30
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry 30
Necrobiosis-Lipoidica-Like Skin Lesions in a Patient with Non-Systemic Sarcoidosis 30
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 30
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 30
Erythema Multiforme Induced by Secukinumab: Clinical, Dermoscopic, and Histological Features 29
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 29
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry 29
Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future 28
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 28
Inflammation as a mediator of the association between osteoporosis and hearing loss in older subjects: a population-based study 28
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile 28
Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints 27
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 27
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 27
Primary versus systemic-sclerosis-associated Raynaud's phenomenon: relationship with clinical and environmental factors 27
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 27
Targeted synthetic pharmacotherapy for psoriatic arthritis: state of the art 27
Endothelial-to-mesenchymal transition in systemic sclerosis 27
Utility of ultrasound in the diagnosis of chronic worsened gout 26
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 26
Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity 26
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 26
Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis 26
Totale 6.553
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.006
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.006
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022119 0 1 2 0 0 0 2 4 21 6 2 81
2022/2023165 1 0 5 4 60 0 6 5 6 7 63 8
2023/2024422 16 53 18 50 45 164 8 18 7 12 21 10
2024/20254.807 49 58 141 90 92 131 73 21 321 328 1.545 1.958
2025/20261.757 490 229 479 528 31 0 0 0 0 0 0 0
Totale 7.270